Yuichi Ando Selected Research

UGT1A1 enzyme

4/2014	Association between severe toxicity of nilotinib and UGT1A1 polymorphisms in Japanese patients with chronic myelogenous leukemia.
5/2011	Regimen selection for first-line FOLFIRI and FOLFOX based on UGT1A1 genotype and physical background is feasible in Japanese patients with advanced colorectal cancer.
2/2011	Phase I/II study of FOLFIRI in Japanese patients with advanced colorectal cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yuichi Ando Research Topics

Disease

67	Neoplasms (Cancer) 10/2022 - 02/2002
13	Colorectal Neoplasms (Colorectal Cancer) 05/2022 - 11/2008
10	Diarrhea 11/2021 - 02/2002
8	Neutropenia 01/2021 - 01/2005
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 10/2004
6	Thrombocytopenia (Thrombopenia) 01/2022 - 05/2011
6	Breast Neoplasms (Breast Cancer) 09/2020 - 10/2015
6	Hypertension (High Blood Pressure) 01/2019 - 02/2013
5	Exanthema (Rash) 10/2022 - 03/2014
5	Stomach Neoplasms (Stomach Cancer) 01/2022 - 03/2016
5	Disease Progression 10/2021 - 06/2005
5	Neoplasm Metastasis (Metastasis) 02/2016 - 02/2002
4	Febrile Neutropenia 01/2020 - 05/2011
4	Nausea 01/2018 - 02/2010
4	Vomiting 01/2018 - 02/2010
4	Ovarian Neoplasms (Ovarian Cancer) 05/2015 - 09/2010
4	Drug-Related Side Effects and Adverse Reactions 12/2014 - 01/2005
3	Esophageal Neoplasms (Esophageal Cancer) 12/2022 - 10/2014
3	Melanoma (Melanoma, Malignant) 01/2022 - 02/2016
3	Prostatic Neoplasms (Prostate Cancer) 09/2020 - 11/2002
3	Fever (Fevers) 06/2020 - 11/2014
3	Lung Neoplasms (Lung Cancer) 01/2020 - 01/2005
3	Ascites 07/2019 - 05/2011
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2018 - 10/2015
3	Cancer Pain 01/2018 - 02/2010
3	Periodontitis 09/2017 - 10/2010
3	Pain (Aches) 01/2015 - 04/2014
3	Periodontal Diseases (Periodontal Disease) 05/2013 - 12/2002
3	Leukopenia 01/2005 - 02/2002
2	Infections 10/2022 - 01/2020
2	Vitiligo 01/2022 - 01/2022
2	Amelanotic Melanoma (Amelanotic Melanomas) 01/2022 - 01/2022
2	Cardiotoxicity 07/2021 - 03/2017
2	Cardiovascular Diseases (Cardiovascular Disease) 07/2021 - 03/2017
2	Aggressive Fibromatosis (Desmoid) 11/2020 - 12/2015
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2020 - 11/2014
2	Choriocarcinoma 09/2017 - 11/2016
2	Dental Caries (Decay, Dental) 11/2016 - 12/2013
2	Body Weight (Weight, Body) 11/2016 - 12/2015
2	Fatigue 10/2016 - 12/2015
2	Hyperbilirubinemia 02/2016 - 04/2014
2	Liver Diseases (Liver Disease) 02/2016 - 01/2013

Drug/Important Bio-Agent (IBA)

20	Irinotecan (Camptosar)FDA LinkGeneric 01/2020 - 02/2002
16	Pharmaceutical PreparationsIBA 01/2022 - 02/2002
12	Oxaliplatin (Eloxatin)FDA LinkGeneric 05/2022 - 05/2011
9	Immune Checkpoint InhibitorsIBA 01/2022 - 03/2018
9	Carboplatin (JM8)FDA LinkGeneric 03/2017 - 06/2005
8	Fluorouracil (Carac)FDA LinkGeneric 12/2022 - 05/2008
8	Bevacizumab (Avastin)FDA Link 05/2022 - 02/2013
6	Cisplatin (Platino)FDA LinkGeneric 12/2022 - 11/2016
6	Docetaxel (Taxotere)FDA Link 12/2022 - 06/2005
6	Capecitabine (Xeloda)FDA Link 01/2021 - 01/2017
6	PlatinumIBA 07/2019 - 02/2014
6	Glucuronosyltransferase (UDP Glucuronosyltransferase)IBA 03/2016 - 05/2002
5	NivolumabIBA 01/2022 - 01/2016
5	Monoclonal AntibodiesIBA 01/2022 - 02/2013
4	Paclitaxel (Taxol)FDA LinkGeneric 10/2022 - 06/2014
4	Gemcitabine FDA Link 11/2020 - 02/2016
4	Biomarkers (Surrogate Marker)IBA 01/2020 - 10/2016
4	Opioid Analgesics (Opioids)IBA 01/2018 - 02/2010
4	Thalidomide (Thalomid)FDA Link 01/2013 - 02/2002
4	Leucovorin (Folinic Acid)FDA Link 08/2011 - 11/2008
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2014
3	Trastuzumab (Herceptin)FDA Link 01/2022 - 03/2017
3	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2021 - 11/2014
3	Lipase (Acid Lipase)FDA Link 01/2021 - 04/2014
3	pazopanib FDA Link 01/2021 - 04/2014
3	130-nm albumin-bound paclitaxelIBA 01/2020 - 01/2018
3	AntiemeticsIBA 01/2018 - 02/2010
3	CreatinineIBA 02/2017 - 02/2011
3	Transaminases (Aminotransferases)IBA 02/2016 - 03/2014
3	UGT1A1 enzymeIBA 04/2014 - 02/2011
2	pegfilgrastim (Neulasta)FDA Link 12/2022 - 02/2018
2	AntibodiesIBA 11/2021 - 03/2018
2	TabletsIBA 01/2021 - 01/2010
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 12/2018
2	Vinblastine (Vinblastine Sulfate)FDA Link 11/2020 - 12/2015
2	CateninsIBA 11/2020 - 12/2015
2	Methotrexate (Mexate)FDA LinkGeneric 11/2020 - 12/2015
2	Tuberculin (PPD)IBA 01/2019 - 05/2013
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2018 - 03/2016
2	Epirubicin (Ellence)FDA LinkGeneric 02/2018 - 03/2016
2	Oxycodone (Oxycontin)FDA LinkGeneric 01/2018 - 10/2014
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 09/2017 - 05/2013
2	taxaneIBA 02/2017 - 12/2012
2	Gefitinib (Iressa)FDA Link 01/2017 - 10/2004
2	FluoridesIBA 11/2016 - 12/2013
2	ToothpastesIBA 11/2016 - 12/2013
2	sonidegibIBA 10/2016 - 02/2015
2	Creatine Kinase (Creatine Phosphokinase)IBA 10/2016 - 02/2016
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016 - 02/2013

Therapy/Procedure

33	Drug Therapy (Chemotherapy) 05/2022 - 05/2002
15	Therapeutics 01/2022 - 08/2011
3	Chemoradiotherapy 07/2019 - 01/2018
2	Intravenous Infusions 05/2022 - 02/2012
2	Immunotherapy 01/2022 - 07/2019
2	Aftercare (After-Treatment) 01/2022 - 01/2020
2	Glycemic Control 09/2017 - 05/2013
2	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 09/2017 - 11/2016
2	Drug Tapering 02/2016 - 10/2015